“…Cancer biomarkers, such as nucleic acids, proteins, and glycans, play a significant role in early diagnosis, cancer progression monitoring, and treatment. , Up to now, these discovered biomarkers have shown different spatial distribution in tumor cells, for instance, some proteins located on the cell membrane and nucleic acids mostly distributed in the cytoplasm. − One interesting finding is that lots of cancer biomarkers are shared in different types of cells, for example, microRNA-21 (miR-21) present in breast and liver cancer cells, , that is, simultaneous monitoring of multiple and multilayer cancer biomarkers in living cells is crucial to acquire precise and multidimensional information in cell types and progression of cancers, which is a big challenge for conventional methods that usually focus on single biomarker detection or monitoring of several related targets with the same spatial locations.…”